In a significant leadership transition for one of Pennsylvania’s largest healthcare systems, Steve Massini, the CEO of Penn State Health, has announced his retirement....
As students across the nation return to school for the new academic year, mental health professionals are sounding alarms about a potential increase in...
As the global population ages, advancements in technology are playing a crucial role in transforming elderly care. Innovations designed to enhance the quality of...
As mail-order medications become increasingly popular, a heated debate is emerging over the need for more stringent temperature tracking during the shipping process. This...
A new “tariff deal” between the United States and China may have cooled trade tensions — but it’s igniting fresh challenges inside America’s healthcare system. As tariffs on medical devices and pharmaceuticals remain in place, hospitals face rising costs, and seniors could soon pay more for prescriptions and essential care. This in-depth analysis explores how shifting America tariffs and the current tariff status threaten to reshape the economics of elder care, drug access, and the future of U.S. health innovation.